3 critical SII vaccines to cost 20% more | India News
Representative photo (AP) NEW DELHI: Drug price regulator National Pharmaceuticals Pricing Authority (NPPA) has approved a 20% price hike for Serum Institute of India‘s BCG, measles and measles-rubella vaccines.This move is unusual since price hikes are rare when one company dominates the market.NPPA had fixed the pr-ice ceiling in Dec 2024 based on Pharmarack data…